Neurocognitive effects of methamphetamine: a critical review and meta-analysis - PubMed (original) (raw)

Review

Neurocognitive effects of methamphetamine: a critical review and meta-analysis

J Cobb Scott et al. Neuropsychol Rev. 2007 Sep.

Abstract

This review provides a critical analysis of the central nervous system effects of acute and chronic methamphetamine (MA) use, which is linked to numerous adverse psychosocial, neuropsychiatric, and medical problems. A meta-analysis of the neuropsychological effects of MA abuse/dependence revealed broadly medium effect sizes, showing deficits in episodic memory, executive functions, information processing speed, motor skills, language, and visuoconstructional abilities. The neuropsychological deficits associated with MA abuse/dependence are interpreted with regard to their possible neural mechanisms, most notably MA-associated frontostriatal neurotoxicity. In addition, potential explanatory factors are considered, including demographics (e.g., gender), MA use characteristics (e.g., duration of abstinence), and the influence of common psychiatric (e.g., other substance-related disorders) and neuromedical (e.g., HIV infection) comorbidities. Finally, these findings are discussed with respect to their potential contribution to the clinical management of persons with MA abuse/dependence.

PubMed Disclaimer

Similar articles

• Neuropsychological function and delay discounting in methamphetamine-dependent individuals.
  Hoffman WF, Moore M, Templin R, McFarland B, Hitzemann RJ, Mitchell SH. Hoffman WF, et al. Psychopharmacology (Berl). 2006 Oct;188(2):162-70. doi: 10.1007/s00213-006-0494-0. Epub 2006 Aug 17. Psychopharmacology (Berl). 2006. PMID: 16915378
• Social cognition and aggression in methamphetamine dependence with and without a history of psychosis.
  Uhlmann A, Ipser JC, Wilson D, Stein DJ. Uhlmann A, et al. Metab Brain Dis. 2018 Apr;33(2):559-568. doi: 10.1007/s11011-017-0157-3. Epub 2017 Dec 9. Metab Brain Dis. 2018. PMID: 29224181
• Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection.
  Carey CL, Woods SP, Rippeth JD, Gonzalez R, Heaton RK, Grant I. Carey CL, et al. AIDS Behav. 2006 Mar;10(2):185-90. doi: 10.1007/s10461-005-9056-4. AIDS Behav. 2006. PMID: 16477511
• Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review.
  Nordahl TE, Salo R, Leamon M. Nordahl TE, et al. J Neuropsychiatry Clin Neurosci. 2003 Summer;15(3):317-25. doi: 10.1176/jnp.15.3.317. J Neuropsychiatry Clin Neurosci. 2003. PMID: 12928507 Review.
• Implications of chronic methamphetamine use: a literature review.
  Meredith CW, Jaffe C, Ang-Lee K, Saxon AJ. Meredith CW, et al. Harv Rev Psychiatry. 2005 May-Jun;13(3):141-54. doi: 10.1080/10673220591003605. Harv Rev Psychiatry. 2005. PMID: 16020027 Review.

Cited by

• The distinct functional brain network and its association with psychotic symptom severity in men with methamphetamine-associated psychosis.
  Hwang ZA, Hsu AL, Li CW, Wu CW, Chen CH, Chan WP, Huang MC. Hwang ZA, et al. BMC Psychiatry. 2024 Oct 10;24(1):671. doi: 10.1186/s12888-024-06112-4. BMC Psychiatry. 2024. PMID: 39390430 Free PMC article.
• The development and validation of a knowledge, attitude, and practice questionnaire of methamphetamine use.
  Azmi AD, Wahab S, Abdul Kadir NB, Abdul Wahab NA, Razak RA. Azmi AD, et al. Sci Rep. 2024 Sep 18;14(1):21835. doi: 10.1038/s41598-024-73126-z. Sci Rep. 2024. PMID: 39294411 Free PMC article.
• Bioinformatics-driven untargeted metabolomic profiling for clinical screening of methamphetamine abuse.
  Kesmen E, Asliyüksek H, Kök AN, Şenol C, Özli S, Senol O. Kesmen E, et al. Forensic Toxicol. 2024 Sep 18. doi: 10.1007/s11419-024-00703-2. Online ahead of print. Forensic Toxicol. 2024. PMID: 39292360
• Exploring the Acute Effects of Immersive Virtual Reality Biking on Self-Efficacy and Attention of Individuals in the Treatment of Substance Use Disorders: A Feasibility Study.
  Touloudi E, Hassandra M, Stavrou VT, Panagiotounis F, Galanis E, Goudas M, Theodorakis Y. Touloudi E, et al. Brain Sci. 2024 Jul 18;14(7):724. doi: 10.3390/brainsci14070724. Brain Sci. 2024. PMID: 39061464 Free PMC article.
• Modulation of dlPFC function and decision-making capacity by repetitive transcranial magnetic stimulation in methamphetamine use disorder.
  Liu Q, Cui H, Li J, Shen Y, Zhang L, Zheng H. Liu Q, et al. Transl Psychiatry. 2024 Jul 8;14(1):280. doi: 10.1038/s41398-024-03000-z. Transl Psychiatry. 2024. PMID: 38977700 Free PMC article.

References

1. 1. Neurosci Lett. 2005 Aug 12-19;384(1-2):76-81 - PubMed
2. 1. Biol Psychiatry. 2000 Jul 1;48(1):9-20 - PubMed
3. 1. J Clin Exp Neuropsychol. 2005 Feb;27(2):189-204 - PubMed
4. 1. J Emerg Med. 1999 May-Jun;17(3):469-71 - PubMed
5. 1. Prog Neuropsychopharmacol Biol Psychiatry. 1997 Jul;21(5):789-96 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Springer

• Medical

  • MedlinePlus Health Information